Searched for
ARROW PHARMA
Stock market update: Nifty Pharma index falls 1.46% in a weak marketThe Nifty Pharma index was trading 1.46 per cent down at 21582.1.- Stock market update: Nifty Pharma index advances 0.52% in a weak marketThe Nifty Pharma index was trading 0.52 per cent up at 19224.85.
- Stock market update: Nifty Pharma index falls 0.14%The Nifty Pharma index closed 0.14 per cent down at 11683.95.
- Stock market update: Nifty Pharma index falls 0.45% in a weak marketThe Nifty Pharma index was trading 0.45 per cent down at 11647.35.
- Stock market update: Nifty Pharma index advances 0.78%The Nifty Pharma index closed 0.78 per cent up at 12721.0.
- Sensex rises! These stocks are up over 10% on BSEIn the Nifty 50 index, 23 stocks were trading in the green, while 27 stocks were trading in the red.
- Natco Pharma announces launch of first generic of top selling cancer drug RevlimidRevlimid had annual sales of $2.3 billion as of December 2021, according to IQVIA data. The generic version of Revlimid will be available i...
- Natco Pharma gets American drug regulator's nod for generic cancer treatment drugNatco, along with its marketing partner Arrow International previously settled the Paragraph IV litigation related to the product with Celg...
- Batches of Strides' Ranitidine tablets now available for sale in AustraliaOut of the 135 batches of Ranitidine which were tested by TGA, 109 batches were found to have an NDMA level at or above the acceptable limi...
- Strides Pharma arm signs pacts for sale of Australian business to Arrow PharmaThe company said it expects the transaction to close on or around July 10, 2019.
- Strides to exit investment in Arrow for AUD 394 millionIn a separate filing, the company said its step-down subsidiary Strides Pharma Inc has entered into an arrangement to acquire 100 per cent ...
- Australian Competition and Consumer Commission clears Arrow and Apotex merger: StridesIn May 2018, Strides Pharma Science Ltd announced their intention to merge Arrow Pharmaceuticals and Apotex Australia into a new company.
- Check out the stocks that jumped 20% on FridayAll sectoral indices closed in the green on NSE on Friday, with Nifty Metal leading.
- Arrow Pharma acquires Australian operations of Amneal PharmaUnder the terms of the agreement, Arrow Pharmaceuticals will acquire 100 per cent of the issued capital of Amneal Pharmaceutical Pty Ltd Au...
- Strides Shasun frontrunner to buy iNova Pharma: SourceAt 10:00 am, shares of Strides Shasun were trading 1 per cent higher at Rs 1,100. It hit a low of Rs 1,085 and a high of Rs 1,109 in the fi...
- Aurobindo arm to acquire select products in France from Teva"This acquisition will enable Arrow Generiques to continue to increase its branded products portfolio and leverage its position as a key pl...
- Strides Shasun plans to divest British subsidiary for Rs 240 croreThe supply agreement is an extension to the existing supply arrangement previously in place between Pharmacy Alliance and Aspen.
- See benefits from Shasun Pharma merger in next three-four quarters: Arun Kumar, Strides Arcolab"So far as the Australian business is concerned, the generic market is a very small market considering the size of the population."
- Strides Arcolab to get product pipeline developed by AspenStrides Arcolab has said its deal with Aspen Pharmacare to buy the latter's Australia assets will help the Indian drug company rebuild its ...
- Arrow Coated looks to wrap up Adept PolymersArrow Coated Products, a mid-sized packaging firm, is looking to acquire Adept Polymers, a subsidiary of the UK-based Stanelco, one of the ...
Load More
